Brexit, the NHS and Health Law

The NHS was a key issue in the Brexit debates, but the question of NHS funding and enhancement is complex and has implications for delivery of services, access to drugs, patient mobility, and professional mobility. This book examines the impact of Brexit on law and policy in the NHS, highlighting challenges for the devolved jurisdictions and the enhanced rights provided by the EU for UK patients and those from other member states. It also explores the impact on health care professionals, public health law and policy, pharmaceutical regulation, and pharmacovigilance networks.

Format: Hardback
Length: 128 pages
Publication date: 02 October 2024
Publisher: Taylor & Francis Ltd

The NHS played a significant role in the Brexit debates, with promises of increased resources being made on a red bus. However, the issue of NHS funding and enhancement is just one aspect of a complex relationship between EU law and the NHS. Brexit has far-reaching implications for the NHS, including delivery of services, access to drugs, patient mobility, and professional mobility. This book explores the immediate, intermediate, and long-term impact of Brexit on law and policy in the NHS, as well as the challenges posed by Brexit for devolved jurisdictions. It highlights the enhanced rights provided by the EU to UK patients and patients from other member states, including free movement principles, regulation 883/2004, and the Patients Rights Directive. It also examines the potential impact of Brexit on health care professionals, loss of mutual recognition schemes, public health law and policy, pharmaceutical regulation, and pharmacovigilance networks. By highlighting these challenges, this book will be a valuable resource for students, scholars, policy makers, and practitioners of European Law and Health Law.

Dimension: 216 x 138 (mm)
ISBN-13: 9780367075057